Drug Profile
Research programme: HIV vaccines - BIIR/INSERM-ARNS
Alternative Names: anti-CD-40 HIV antibody - BIIR/INSERM-ARNSLatest Information Update: 30 Mar 2023
Price :
$50
*
At a glance
- Originator Baylor Institute for Immunology Research
- Developer Baylor Institute for Immunology Research; INSERM
- Class Dendritic cell vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections